4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Neuropathy: new trials by email Literature Review of Neuropathy trials Research Report on Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet Polyamines depleted diet, associating Polydol® cans and predefined menus low in polyamines - Neuropathy, Digestive Cancer System | Phase 3 | Completed | University Hospital, Clermont-Ferrand | 80 | 2013-02-02 | 2017-07-11 |
| Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy calcium gluconate, magnesium sulfate, placebo - Chemotherapeutic Agent Toxicity, Colorectal Cancer | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 362 | 2010-06-01 | 2022-11-03 |
| Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer Carboplatin, Glutathione, Laboratory Biomarker Analysis - Chemotherapeutic Agent Toxicity, Neuropathy | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 195 | 2009-12-01 | 2017-02-23 |
| S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo acetyl-L-carnitine hydrochloride, placebo - Breast Cancer, Chemotherapeutic Agent Toxicity | Phase 3 | Completed | SWOG Cancer Research Network | 437 | 2009-09-01 | 2017-08-14 |
Neurotoxicity Syndromes (3) · Breast Neoplasms (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Digestive System Neoplasms (1) · Fallopian Tube Neoplasms (1) · Fatigue (1) · Hyperalgesia (1) · Ovarian Neoplasms (1) · Pain (1) · Paresthesia (1) · Rectal Neoplasms (1)
Neoplasms (4) · Neoplasms by Site (4) · Nervous System Diseases (4) · Chemically-Induced Disorders (3) · Pathological Conditions, Signs and Symptoms (3) · Poisoning (3) · Signs and Symptoms (3) · Digestive System Diseases (2) · Neurologic Manifestations (2) · Adnexal Diseases (1) · Breast Diseases (1) · Colonic Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1)
Calcium Gluconate (1) · Carboplatin (1) · Glutathione (1) · Magnesium Sulfate (1) · Oxaliplatin (1) · Paclitaxel (1) · Polyamines (1) · Taxes (1)
Alliance for Clinical Trials in Oncology (2) · SWOG Cancer Research Network (1) · University Hospital, Clermont-Ferrand (1)
United States (3) · France (1) · Puerto Rico (1)
Charles L. Loprinzi, MD (1) · Charles Loprinzi (1) · Laurence H. Baker, DO, FACOI (1)
PMID 23733756, PMID 24297951, PMID 25833669, PMID 34176021
U10CA037404 (1), U10CA037429 (1)